The Australian New Zealand Clinical Trials Registry (ANZCTR) and the ClinicalTrials.gov database are the two places to search for active trials recruiting participants in Australia
Refinement was performed using Refinement embedded in the PHENIX suite 76,77
In the 30-49 age group, 3% had used GLP-1s to treat chronic conditions, 6% for weight loss, and 2% for both
Weight loss injections have become increasingly prevalent in clinical practice, with glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) leading the therapeutic landscape
We walk you through proper reconstitution, injection technique, and storage
Synthesis and applications of bicyclic sugar modified locked nucleic acids: a review